Avidity of human T cell receptor engineered CD4+ T cells drives T-helper differentiation fate

Abstract

The role of the T cell receptor (TCR) in antigen recognition and activation of T lymphocytes is well established. However, how the TCR affects T-helper differentiation/skewing is less well understood, particularly for human CD4+ (CD4) T cell subsets. Here we investigate the role of TCR specific antigen avidity in differentiation and maintenance of human Th1, Th2 and Th17 subsets. Two human TCRs, both specific for the same peptide antigen but with different avidities, were cloned and expressed in human CD4 T cells. These TCR engineered cells were then stimulated with specific antigen in unskewed and T-helper skewed conditions. We show that TCR avidity can control the percentage of IL-4 and IFN-γ co-expression in unskewed TCR engineered cells, that effector function can be maintained in a TCR avidity-dependent manner in skewed TCR engineered cells, and that increased TCR avidity can accelerate Th1 skewing of TCR engineered cells.

HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis

“…Our current data support that HLA-DR-SPs can be recognized as nominal antigens that share similarities with peptides from foreign antigens or potentially “pathogenic” SPs, but we cannot exclude that they may also act as co-agonists via integration in the immunological synapse ( Krogsgaard et al., 2005 ) or that the specificity of TCR is determined by recognizing the backbone of the HLA molecules ( Cai and Hafler, 2007 ). Also, how and whether recognition of the different peptides influences functional differentiation into specific Th subtypes ( Adair et al., 2016 ) remains to be studied.…”

Helper T Cells in Idiopathic Membranous Nephropathy

“…There are many inducing factors of autoimmune diseases, such as the change in autoantigen, the abnormality of immune system, genetic factors, gender and age, etc., as well as their combined forces ( 63 ). IMN is usually caused by a single antigen, of which PLA2R accounts for 75%, and 10%-20% of IMN patients have not yet been identified with their antigens ( 64 ).…”

From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance

“…With this approach, we obtained large numbers of expanded FVIII-specific T cells expressing the 17195 or 171911 TCRs that we demonstrated were highly reactive to the FVIII peptides, albeit with different affinities based on the affinity of the initial clones ( 57 ). The transduced T effectors proliferated and produced cytokines in response to the FVIII peptide (pC2, 2191–2210) on appropriate DR1 APCs just as effectively as anti-CD3 stimulation of the donors; moreover, specific antigen led to an expansion of the cells expressing the TCR as evidenced by tetramer binding ( 30 ).…”